Fulgent Genetics (FLGT) Change in Accured Expenses (2015 - 2026)

Fulgent Genetics has disclosed Change in Accured Expenses across 12 years of filings, most recently posting -$11.9 million for Q2 2026.

• In Q2 2026, Change in Accured Expenses fell 328.64% year-over-year to -$11.9 million; the TTM figure through Jun 2026 stood at -$2.8 million (up 18.82% YoY), while the FY2025 annual figure was $8.9 million, up 324.97% from the prior year.
• Change in Accured Expenses came in at -$11.9 million for Q2 2026 at Fulgent Genetics, down from -$2.1 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $12.3 million in Q4 2025 to a low of -$13.2 million in Q3 2022.
• Average Change in Accured Expenses over 5 years is -$959222.2, with a median of -$654500.0 recorded in 2023.
• Year-over-year, Change in Accured Expenses tumbled 932.2% in 2024 and surged 1862.58% in 2025.
• Over 5 years, Change in Accured Expenses stood at $2.0 million in 2022, then surged by 423.32% to $10.4 million in 2023, then sank by 93.97% to $628000.0 in 2024, then surged by 1862.58% to $12.3 million in 2025, then tumbled by 196.52% to -$11.9 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$11.9 million in Q2 2026, -$2.1 million in Q1 2026, and $12.3 million in Q4 2025.